5‐alpha‐reductase inhibitors are associated with reduced frequency of COVID‐19 symptoms in males with androgenetic alopecia. (22nd November 2020) - McCoy, J.; Cadegiani, F.A.; Wambier, C.G.; Herrera, S.; Vaño‐Galván, S.; Mesinkovska, N.A.; Ramos, P.M.; Shapiro, J.; Sinclair, R.; Tosti, A.; Goren, A.